GNH USA

Europe — EMA

Noradrenaline (Norepinephrine) Aguettant (Noradrenaline Tartrate)

GNH USA supplies Noradrenaline (Norepinephrine) Aguettant, a vasopressor for hypotension, septic shock, cardiogenic shock, and cardiac arrest.

Noradrenaline Tartrate

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Norepinephrine, the active ingredient in Noradrenaline (Norepinephrine) Aguettant, is a sympathomimetic presented as an injection for intravenous use. It treats severe hypotension and various shock states in critically ill patients.

GNH USA supplies Noradrenaline (Norepinephrine) Aguettant as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

What is Noradrenaline Tartrate used for?

Noradrenaline (norepinephrine) is a vasopressor used in acute circulatory failure and related shock conditions. - Hypotension: restores arterial pressure in severe low‑blood‑pressure episodes. - Septic shock: improves perfusion pressure when sepsis causes distributive shock. - Cardiogenic shock: supports cardiac output and systemic vascular resistance in pump failure. - Cardiac arrest: provides vasoconstriction to maintain coronary perfusion during resuscitation.

What are the side effects of Noradrenaline Tartrate?

Norepinephrine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Tachycardia: increased heart rate. - Hypertension: elevated blood pressure. - Headache: pressure sensation. - Anxiety or restlessness. - Peripheral ischemia: reduced blood flow to extremities. - Arrhythmia: irregular heart rhythm.

Serious or Rare Side Effects: - Myocardial ischemia: reduced heart muscle blood supply. - Severe hypertension: dangerously high blood pressure. - Tissue necrosis at infusion site. - Life‑threatening arrhythmic events. - Pulmonary edema: fluid accumulation in lungs. - Severe bradycardia: dangerously low heart rate.

What precautions apply to Noradrenaline Tartrate?

Noradrenaline requires careful monitoring and specific safety measures before and during use. - Cardiovascular monitoring: continuous blood pressure and heart‑rate observation is essential. - Dosage titration: infusion rate should be adjusted according to hemodynamic response. - Contraindications: avoid in patients with uncorrected tachyarrhythmias. - Drug interactions: monitor closely when combined with MAO inhibitors or other pressor agents. - Pregnancy: use only if potential benefit justifies potential risk to the fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Noradrenaline Tartrate interact with?

Norepinephrine can interact with several drug classes, requiring vigilance to prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - Tricyclic antidepressants: additive pressor effects. - Beta‑blockers: can blunt desired cardiac response. - Vasopressin: excessive vasoconstriction risk.

Moderate Interactions (Monitor Closely): - Inhaled anesthetics: may potentiate hypotension. - Calcium channel blockers: may alter vascular tone. - Diuretics: can affect intravascular volume and response.

Frequently asked questions

What is Noradrenaline (Norepinephrine) Aguettant used for?+
Noradrenaline (Norepinephrine) Aguettant is an injectable vasopressor indicated for the rapid restoration of blood pressure in severe hypotension, septic shock, cardiogenic shock, and during cardiac arrest. It is employed in intensive‑care settings where immediate hemodynamic support is required.
How does norepinephrine work?+
Norepinephrine activates alpha‑1 adrenergic receptors, causing peripheral vasoconstriction, and beta‑1 receptors, increasing heart rate and contractility. The combined effect raises systemic vascular resistance and cardiac output, quickly improving blood pressure and organ perfusion in shock states.
What is the usual dose of Noradrenaline (Norepinephrine) Aguettant?+
The specific infusion rate and total dose are determined by the prescribing clinician based on the patient’s hemodynamic status, target blood pressure, and response to therapy. No fixed regimen is provided; dosing is individualized and titrated in real time.
Is Noradrenaline safe in pregnancy or breastfeeding?+
Safety data for norepinephrine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.
How do I order Noradrenaline (Norepinephrine) Aguettant from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does norepinephrine compare with epinephrine?+
Both are catecholamine vasopressors, but norepinephrine has stronger alpha‑1 activity and weaker beta‑2 effects, making it more effective for raising systemic vascular resistance without significant bronchodilation. Epinephrine provides more pronounced beta‑1 and beta‑2 stimulation, which can be advantageous in anaphylaxis but may cause greater tachycardia.
What are the storage and handling requirements for this product?+
Noradrenaline (Norepinephrine) Aguettant should be stored refrigerated at 2‑8 °C, protected from light, and never frozen. The vial must be kept in its original packaging, and the solution should not be shaken vigorously before use.
How is Noradrenaline (Norepinephrine) Aguettant administered?+
The drug is supplied as a sterile injectable solution for intravenous infusion. It is typically administered through a calibrated infusion pump, allowing precise titration of the dose while continuous hemodynamic monitoring is performed.
What are the most serious risks to watch for when using norepinephrine?+
Critical risks include severe hypertension, myocardial ischemia, arrhythmias, tissue necrosis at the infusion site, and pulmonary edema. Immediate recognition and management of these events are essential, and continuous cardiovascular monitoring is mandatory during therapy.
Who should not use Noradrenaline (Norepinephrine) Aguettant?+
Patients with uncorrected tachyarrhythmias, severe peripheral vascular disease, or known hypersensitivity to norepinephrine or any excipients should not receive this medication. Use is also contraindicated in patients where excessive vasoconstriction could worsen tissue perfusion.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Laboratoire Aguettant
Origin
EU

Related products

Cronomir

Cronomir

Noradrenaline Tartrate

Laboratoire Aguettant
EU
L-Noradrenalina Braun

L-Noradrenalina Braun

Noradrenaline Tartrate

B. Braun Medical Lda.
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU